Johnson & Johnson has dropped a pair of CAR-T cell therapies, axing programs it once predicted could deliver peak sales north ...
Single agent duvelisib demonstrated clinically meaningful response rates, including a substantial proportion of complete responses, in a heavily pretreated PTCL population Responses highest in ...
The peripheral T-cell lymphoma treatment market is witnessing steady growth, primarily driven by the increasing incidence, leading to an increased patient population, which fuels the ongoing treatment ...
Following his cancer-free announcement Sam Neill highlights the need to make immunotherapy accessible to more people globally ...
Walton High School student-athletes are rallying around Dickerson Middle School sixth grader Jackson Jefcoat as he undergoes ...
The National Institute for Health and Care Excellence (NICE) has approved a chimeric antigen receptor (CAR) T-cell therapy for adults with large B-cell lymphoma. The treatment significantly delays ...
Allogene Therapeutics’ gamble on a never-before-seen trial strategy seems to be paying off, with the biotech’s off-the-shelf cell therapy eradicating residual lymphoma in over half of evaluated pat | ...
"Now I'm a living man, with every intent of going on living and living and living," the 'Jurassic Park' actor wrote in his ...
While rare, secondary cancers after CAR T-cell therapy have been reported, leading the FDA to mandate boxed warnings on all approved therapies. In a first, targeted therapy was used to treat a T-cell ...
Hollywood veteran Sam Neill is opening up about his nearly five-year health battle. In 2023, the “Jurassic Park” alum ...
( KTLA) — Hollywood actor Sam Neill recently announced that he’s cancer-free thanks to a revolutionary new cancer treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results